Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 University Hospitals

Klinische Padiatrie

Volumn 223, Issue 6, 2011, Pages 335-340

  Krenn, T ^a   Fleischhack, G ^b   Moser, O ^b   Dilloo, D ^b   Bode, U ^b   Grber, S ^a   Furtwngler, R ^a   Graf, N ^a   Simon, A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; BACTERIUM DETECTION; CANCER INCIDENCE; CANCER PATIENT; CANCER RELAPSE; CATHETER INFECTION; CHILD; CHILDHOOD CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; ENTEROBACTER CLOACAE; FEMALE; GENDER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SEPSIS; UNIVERSITY HOSPITAL;

EID: 81855222039     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0031-1287838     Document Type: Review

References (29)

1. Adler A, Yaniv I, Steinberg R et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006; 62: 358-365
2. Alexander N. Question 3. Do Portacaths or Hickman lines have a higher risk of catheter-related bloodstream infections in children with leukaemia? Arch Dis Child 2010; 95: 239-241
3. Beutel K, Simon A. Diagnostic and management of central venous line infections in pediatric cancer patients. Klin Padiatr 2005; 217 (Suppl 1 ): S91-S100
4. Bindl L, Nicolai T. Management of septic shock and acquired respiratory distress syndrome in pediatric cancer patients. Klin Padiatr 2005; 217 (Suppl 1 ): S130-S142
5. Cesaro S, Corro R, Pelosin A et al. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients aff ected by hematological and oncological diseases. Ann Hematol 2004; 83: 183-188
6. Cesaro S, Tridello G, Cavaliere M et al. Prospective, randomized trial of two diff erent modalities of fl ushing central venous catheters in pediatric patients with cancer. J Clin Oncol 2009; 27: 2059-2065
7. Franklin J A, Gaur A H, Shenep J L et al. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture. Pediatr Infect Dis J 2004; 23: 614-618
8. Gastmeier P, Sohr D, Geff ers C et al. Are nosocomial infection rates in intensive care units useful benchmark parameters? Infection 2000; 28: 346-350
9. Gaur A H, Flynn P M, Giannini M A et al. Difference in time to detection: a simple method to diff erentiate catheter-related from non-catheterrelated bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 2003; 37: 469-475
10. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: defi nitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2-8
11. Handrup M M, Moller J K, Frydenberg M et al. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 55: 309-313
12. Kersun L S, Propert K J, Lautenbach E et al. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis. Pediatr Blood Cancer 2005; 45: 162-169
13. Laws H J, Ammann R A, Lehrnbecher T. Diagnostic procedures and mana gement of fever in pediatric cancer patients. Klin Padiatr 2005; 217 (Suppl 1 ): S9-S16
14. Lehrnbecher T, Ethier M C, Zaoutis T et al. International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia. Br J Haematol 2009; 147: 125-128
15. Lehrnbecher T, Laws H J, Boehm A et al. Compliance with anti-infective preventive measures: A multicentre survey among paediatric oncology patients. Eur J Cancer 2008; 44: 1861-1865
16. Lehrnbecher T, Stanescu A, Kuhl J. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer. Infection 2002; 30: 17-21
17. Meckler G, Lindemulder S. Fever and neutropenia in pediatric patients with cancer. Emerg Med Clin North Am 2009; 27: 525-544
18. Onland W, Shin C E, Fustar S, Rushing T, Wong W Y. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 2006; 160: 1049-1053
19. Paulus S C, van Saene H K, Hemsworth S et al. A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children's Hospital, Alder Hey, UK. Eur J Cancer 2005; 41: 2132-2140
20. Scheinemann K, Ethier M C, Dupuis L L et al. Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer 2010; 18: 913-919
21. Simon A, Ammann R A, Bode U et al. Nosocomial infections in pediatric cancer patients: results of a prospective surveillance study from 7 University hospitals in Germany and Switzerland. BMC Infect Dis 2008; E-Pub May 23, 2008; 70:
22. Simon A, Ammann R A, Wiszniewsky G et al. Taurolidine-citrate lock solution (TauroLock) signifi cantly reduces CVAD-associated Gram positive infections in paediatric cancer patients. BMC Infectious Diseases 2008; 8: 102
23. Simon A, Beutel K, Hasan A et al., on behalf of the German Society of Pediatric Oncology and Haematology (GPOH). Evidence-based recommendation for the management of long-term central venous access devices in pediatric patients. 3rd Edition ed. Bonn; 2008
24. Simon A, Fleischhack G. Surveillance for nosocomial infections in pediatric hematology/oncology patients. Klin Padiatr 2001; 213: A106-A113
25. Simon A, Fleischhack G, Hasan C et al. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 2000; 21: 592-596
26. Simon A, Fleischhack G, Marklein G et al. Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients. Klin Padiatr 2001; 213: A22-A37
27. Simon A, Fleischhack G, Wiszniewsky G et al. Infl uence of Prolonged Use of Intravenous Administration Sets in Paediatric Cancer Patients on CVAD-related Bloodstream Infection Rates and Hospital Resources. Infection 2006; 34: 258-263
28. Simon A, Groger N, Wilkesmann A et al. Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia. Int J Antimicrob Agents 2006; 28: 417-422
29. Sleijfer D T, Mulder N H, de Vries-Hospers H G et al. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 1980; 16: 859-869